Rolhion, Nathalie

Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation

Lamas, B., Hernandez-Galan, L., Galipeau, H. J., Constante, M., Clarizio, A., Jury, J., Breyner, N. M., Caminero, A., Rueda, G., Hayes, C. L., et al. (2020) · Science Translational Medicine

Celiac Disease Research and ManagementGut microbiota and health

Cited by 179

Recipient factors in faecal microbiota transplantation: one stool does not fit all

Danne, C., Rolhion, N., & Sokol, H. (2021) · Nature Reviews Gastroenterology & Hepatology

Gut microbiota and healthClostridium difficile and Clostridium perfringens research

Cited by 154

Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression

Raisch, J., Rolhion, N., Dubois, A., Darfeuille-Michaud, A., & Bringer, M.-A. (2015) · Laboratory Investigation

Escherichia coli research studiesImmune cells in cancer

Cited by 100

Human CD4+CD8α+ Tregs induced by Faecalibacterium prausnitzii protect against intestinal inflammation

Touch, S., Godefroy, E., Rolhion, N., Danne, C., Oeuvray, C., Straube, M., Galbert, C., Brot, L., Alonso Salgueiro, I., Chadi, S., et al. (2022) · JCI Insight

Inflammatory Bowel DiseaseT-cell and B-cell Immunology

Cited by 80

Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors

Bredon, M., Danne, C., Pham, H. P., Ruffié, P., Bessede, A., Rolhion, N., Creusot, L., Brot, L., Alonso, I., Langella, P., et al. (2024) · OncoImmunology

Cancer Immunotherapy and BiomarkersGut microbiota and health

Cited by 74